During the past decade, LIMOGES - CHU Dupuytren 1 conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "LIMOGES - CHU Dupuytren 1" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "French Intergroup of Myeloproliferative syndromes" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "LIMOGES - CHU Dupuytren 1" are "Acute Myeloid Leukemia" (1 trials), "CLL/SLL" (1 trials), "Multiple Myeloma" (1 trials), "Myeloproliferative Syndrome" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "LIMOGES - CHU Dupuytren 1" in a lesser frequency.

Most popular intervention types in "LIMOGES - CHU Dupuytren 1" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "BIRT 2584 XX" (1 trials), "CPX-351" (1 trials), "First line therapy" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "LIMOGES - CHU Dupuytren 1" are 4 trials for "All" genders.

Currently, there are NaN active trials in "LIMOGES - CHU Dupuytren 1". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LIMOGES - CHU Dupuytren 1, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LIMOGES - CHU Dupuytren 1, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".